# LSNE Madison LLC – FDA 483, Oct 16, 2025

Source: https://www.keypedia.com/records/483/lsne-madison-llc/fe46f962-077c-4a53-8293-3351f47df7ff

> FDA 483 for LSNE Madison LLC on October 16, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: LSNE Madison LLC
- Inspection Date: 2025-10-16
- Product Type: drugs
- Office Name: Minneapolis District Office
- Summary: LSNE Madison, LLC dba PCI Pharma Services Company, a contract manufacturer in Madison, WI, was cited for significant deficiencies in its aseptic processing areas. The inspection revealed inadequate validation of cleaning and disinfecting processes for sterile operations, particularly concerning the Restricted Access Barrier System (RABS). Additionally, the firm failed to adhere to its established standard operating procedures for both ISO room cleaning and aseptic technique during manufacturing activities.

## Related Documents

- [483 - 2024-10-11](https://www.keypedia.com/records/483/lsne-madison-llc/96855540-ce5b-45e8-b1a0-a26cfcf88f94) — date: October 11, 2024

## Related Officers

- [Lori B. Wikstrom](https://www.keypedia.com/people/lori-b-wikstrom/19d938f7-4a5d-42b9-b2d1-e92cdb63bb0d)
- [Lori B. Wilkstrom](https://www.keypedia.com/people/lori-b-wilkstrom/541f4a17-d0d3-4a8e-a105-13f18c8bc4c4)

Company: https://www.keypedia.com/companies/lsne-madison-llc/97b52716-6508-4868-9609-761c6bc02db4

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d
